Your session is about to expire
← Back to Search
Partial VEPMP Intervention for Pneumonia
N/A
Waitlist Available
Led By Mohsen Bazargan, PhD
Research Sponsored by Charles Drew University of Medicine and Science
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Parishioner at a church receiving the VEPMP intervention
Identify as African American or Latinx
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intervention: 12 months; follow-up point: 9 & 18 months post-intervention
Awards & highlights
Study Summary
This study is evaluating whether a community-based intervention can help increase vaccination rates for underserved populations.
Eligible Conditions
- Influenza
- Pneumonia
- Coronavirus
- Vaccine Refusal
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ intervention: 12 months; follow-up point: 9 & 18 months post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intervention: 12 months; follow-up point: 9 & 18 months post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Prevalence of vaccination uptake for COVID-19, influenza, and pneumonia using Vaccination History Self Report
Secondary outcome measures
Percentage of Participants Achieving Adherence to COVID-19, influenza, and pneumonia vaccination schedules Risk Using the NIH Toolbox Surveys on COVID-19
Percentage of Participants Achieving Decreased Levels of COVID-19, influenza, and pneumonia Mistrust and Barriers Using the NIH Toolbox Surveys on COVID-19, influenza, and pneumonia
Percentage of Participants Achieving Decreased Vaccine Hesitancy Levels of COVID-19, influenza, and pneumonia Using the NIH Toolbox Surveys on COVID-19, influenza, and pneumonia
Trial Design
3Treatment groups
Experimental Treatment
Group I: Arm 3Experimental Treatment1 Intervention
This arm will include 5 churches who will receive all study activities in the Vaccine Education Promotion Management Plan following completion of Arm 1 and 2.
Group II: Arm 2Experimental Treatment1 Intervention
This arm will include 5 churches who will receive some study activities in the Vaccine Education Promotion Management Plan
Group III: Arm 1Experimental Treatment1 Intervention
This arm will include 5 churches who will receive all study activities in the Vaccine Education Promotion Management Plan
Find a Location
Who is running the clinical trial?
Charles Drew University of Medicine and ScienceLead Sponsor
51 Previous Clinical Trials
6,637 Total Patients Enrolled
1 Trials studying Pneumonia
600 Patients Enrolled for Pneumonia
Mohsen Bazargan, PhDPrincipal InvestigatorCharles R. Drew University of Medicine & Science
2 Previous Clinical Trials
150 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger